About

HIV in the Greater Washington Region

In recent years, Washington, D.C. has made tremendous progress in getting closer to the city’s goal of ending the local HIV epidemic. But new HIV cases continue to occur: 368 new cases in 2017, and 13,003 D.C. residents are currently living with HIV.[1] Simply living in the District means that a person is more at risk for HIV. D.C. residents have a 1 in 13 chance of receiving an HIV diagnosis in their lifetime. [2] In contrast, for the average American, the chance is 1 in 99.[2]

Communities of color experience the highest rates of HIV infection in Washington, D.C. African Americans account for 69% of newly diagnosed HIV cases while only accounting for 47.1% of the D.C. population.[1] In fact, 4.4% of the District’s African American male population is living with HIV, followed by 2.1% of the male Latinx population, and 1.9% of African American females.[1] According to the WHO, a generalized epidemic rate is 1%; communities of color in D.C. are all above that rate, signifying they are disproportionately impacted by HIV. In total, 10,922 individuals from communities of color are living with HIV, 84% of all living cases.[1] Wards 5, 6, 7, and 8, where the majority of African Americans live, had the highest rates of HIV and the highest poverty rates in the city.[3]

Racial/ethnic disparities also exist in terms of access to and engagement in care. Among those newly diagnosed with HIV in 2012-2016, 80% of white individuals were linked to care within thirty days of diagnosis (considered a best practice), compared to 72% of African Americans.[4] Africans Americans were less likely to have reached HIV viral suppression within 6 months of HIV diagnosis when compared to white individuals.[1] Overall, only 73% of D.C. residents living with HIV were engaged in continuous care (more than one medical visit related to their HIV status) in 2017, and only 65% had achieved HIV viral load suppression, making them less likely to transmit the disease.[1] HIV viral suppression is key to ending the epidemic as it greatly decreases the risk of HIV-positive individuals transmitting the disease to others. Viral suppression cannot be achieved without access to and engagement in care.

In addition to D.C., Northern Virginia and Suburban Maryland have been adversely affected by the HIV epidemic. In Northern Virginia, 8,968 individuals are living with HIV/AIDS, 36% of Virginia’s total.[4] Of Northern Virginians, 61% of those living with HIV were African American or Latinx.[4] In Suburban Maryland, there were 10,614 individuals living with HIV, 36% of Maryland’s total.[5] Among living Suburban Maryland HIV cases, 76.6% were among Black populations, 65.1% were among male-identifying individuals, and 44.7% were attributed to heterosexual contact, followed closely by MSM (44.5%).[5]  Individuals seeking HIV-related services may travel across state lines, so it is important that efforts to eliminate HIV in D.C. are made available to residents of the entire region.

This data clearly demonstrates that while much progress has been made, the Greater Washington region cannot slow down its efforts if the goal is to end the local HIV epidemic. The Washington AIDS Partnership will continue to be on the frontlines of this public health crisis. Read more about our newest projects: Ending the HIV epidemic in D.C., PrEP for Women initiative, and the Mobile Outreach Retention and Engagement initiative, as we work to eliminate new HIV cases, and care for those living with HIV.

[1] DC Annual Epidemiology & Surveillance Report: 3,6-7, 9-10. Released 2017.
[2] CDC. HIV in the United States by Geographic Distribution. 2017.
[3] DC Annual Epidemiology & Surveillance Report: 15. Released 2016. Urban Institute. NeighborhoodInfo DC: March 2017. http://neighborhoodinfodc.org/wards/wards.html. Urban Institute. A Vision for an Equitable DC: March 2017. http://www.urban.org/features/vision-equitable-dc.
[4] Virginia Dept of Health. 2017 VA HIV Surveillance Annual Report: Table 3, 9. Released 2018.

[5] MDHMH. Suburban Regional HIV Annual Epidemiological Profile 2017: 21, 26, 34. Released 2018.